Corpus Intelligence IC Memo — SANFORD ABERDEEN MEDICAL CENTER 2026-04-26 04:04 UTC
IC Memo — SANFORD ABERDEEN MEDICAL CENTER
Investment Committee Memorandum | SD | 48 beds | Grade C | EBITDA uplift $4.7M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

SANFORD ABERDEEN MEDICAL CENTER

CCN 430097 | BROWN, SD | 48 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

SANFORD ABERDEEN MEDICAL CENTER is a 48-bed under-performing / distressed in BROWN, SD with $64.0M in net patient revenue and a -22.7% operating margin. The hospital serves a payer mix of 45.2% Medicare, 13.4% Medicaid, and 41.4% commercial.

Thesis: Turnaround. Our ML models identify $4.7M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -22.7% to -15.3% (+736bps).

Net Revenue HCRIS$64.0M
Current EBITDA COMPUTED$-14.5M
Operating Margin COMPUTED-22.7%
Occupancy HCRIS24.0%
Revenue / Bed COMPUTED$1.3M
Net-to-Gross HCRIS37.2%
Distress Probability ML57.6%

2. Market Context & Competitive Position

63
SD Hospitals
-3.2%
State Median Margin
32
Comparable Hospitals

SD has 63 Medicare-certified hospitals with a median operating margin of -3.2%. The target's margin of -22.7% places it below the state median. Among 32 size-comparable peers (24-96 beds), the median margin is -2.5%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (24-96), prioritizing same-state peers. 32 hospitals in the comp set.

HospitalStateBedsRevenueMargin
SANFORD ABERDEEN MEDICAL CENTE (Target)SD48$64.0M-22.7%
AVERA ST. LUKESSD50$210.6M-7.3%
AVERA HEART HOSPITAL OF SOUTH SD53$139.0M1.5%
SIOUX FALLS SPECIALTY HOSPITALSD33$138.8M31.7%
AVERA QUEEN OF PEACESD50$129.2M-8.7%
PRAIRIE LAKES HEALTH CARE CENTSD69$123.9M-9.8%
AVERA SACRED HEART HOSPITALSD42$123.1M-1.9%
AVERA QUEEN OF PEACESD25$122.9M-5.8%
MONUMENT HEALTH SPEARFISH HOSPSD27$116.6M1.9%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $4.7M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$1.3M+210bp18mo
Cost to Collect4.5%2.5%$1.3M+200bp12mo
Denial Rate Reduction12.0%6.5%$1.3M+198bp12mo
A/R Days Reduction5200.0%3800.0%$779K+122bp9mo
Clean Claim Rate88.0%96.0%$41K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$1.3M
Cost to Collect
$1.3M
Denial Rate Reduction
$1.3M
A/R Days Reduction
$779K
Clean Claim Rate
$41K
Total EBITDA Uplift$4.7M
Current EBITDA$-14.5M
+ RCM Uplift+$4.7M
Pro Forma EBITDA$-9.8M
Current Margin-22.7%
Pro Forma Margin-15.3%
WC Released (1x)$2.5M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-22.3M$-48.5M0.00x-100.0%
Base (11x exit)10.0x11.0x$-22.3M$-60.6M0.00x-100.0%
Bull Case9.0x11.0x$-20.1M$-52.3M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-20.1M$-63.0M0.00x-100.0%
Bear Case11.0x10.0x$-24.5M$-64.8M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-24.5M$-79.3M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumLow occupancyAt 24.0%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 57.6% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 32 hospitals with 24-96 beds
  • Same-state prioritization (n=33)
  • Comp margins: P25=-7.4% / P50=-2.5% / P75=8.8%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.